Wook Kim
Director of Finance/CFO chez HLB GLOBAL CO., LTD.
Postes actifs de Wook Kim
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HLB CO., LTD. | Director/Board Member | - | - |
| HLB GLOBAL CO., LTD. | Director/Board Member | 01/08/2018 | - |
| Director of Finance/CFO | 01/08/2018 | - |
Historique de carrière de Wook Kim
Anciens postes connus de Wook Kim
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Director/Board Member | 01/01/2019 | - |
Formation de Wook Kim
| Korea University | Undergraduate Degree |
Statistiques
Internationale
| Corée du Sud | 4 |
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Energy Minerals | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HLB GLOBAL CO., LTD. | Energy Minerals |
| HLB CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
